Novel Fused Pyrrole Heterocyclic Ring Systems as Structure Analogs of LE 300: Synthesis and Pharmacological Evaluation as Serotonin 5‐HT2A, Dopamine and Histamine H1 Receptor Ligands

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Archiv der Pharmazie

• Publication date

  2010-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/ardp.200900219PMID 20108267
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.

  2009cited by this paper
• Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior.

  2009cited by this paper
• Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands.

  2009cited by this paper
• Synthesis and structure-activity relationships of a series of substituted 2-(1H-furo[2,3-g]indazol-1-yl)ethylamine derivatives as 5-HT2C receptor agonists.

  2008cited by this paper
• Dopamine/serotonin receptor ligands. Part 17: a cross-target SAR approach: affinities of azecine-styled ligands for 5-HT(2A) versus D1 and D2 receptors.

  2008cited by this paper
• High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO): a high-affinity 5-HT2A receptor-selective agonist radioligand.

  2008cited by this paper
• Insights into the regulation of 5-HT2A serotonin receptors by scaffolding proteins and kinases.

  2008cited by this paper
• Dopamine/serotonin receptor ligands. 16.(1) Expanding dibenz[d,g]azecines to 11- and 12-membered homologues. Interaction with dopamine D(1)-D(5) receptors.

  2007cited by this paper
• Dopamine/Serotonin Receptor Ligands. 16.1 Expanding Dibenz[d,g]azecines to 11- and 12-Membered Homologues. Interaction with Dopamine D1−D5 Receptors

  2007cited by this paper
• Rational design, synthesis and evaluation of (6aR( *),11bS( *))-1-(4-fluorophenyl)-4-{7-[4-(4-fluorophenyl)-4-oxobutyl]1,2,3,4,6,6a,7,11b,12,12a(RS)-decahydropyrazino[2',1':6,1]pyrido[3,4-b]indol-2-yl}-butan-1-one as a potential neuroleptic agent.

  2007cited by this paper
• Dopamine/serotonin receptor ligands. 10: SAR Studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist.

  2006cited by this paper
• Hallucinogens.

  2004cited by this paper
• Dopamine/serotonin receptor ligands. Part VIII: the dopamine receptor antagonist LE300 - modelled and X-ray structure plus further pharmacological characterization, including serotonin receptor binding, biogenic amine transporter testing and in vivo testings.

  2004cited by this paper
• Dopamine/serotonin receptor ligands. 9. Oxygen-containing midsized heterocyclic ring systems and nonrigidized analogues. A step toward dopamine D5 receptor selectivity.

  2004cited by this paper
• Dopamine Receptor Ligands. Part VII [1]: Novel 3‐Substituted 5‐Phenyl‐1, 2, 3, 4, 5, 6‐hexahydro‐azepino‐[4, 5‐b]indoles as Ligands for the Dopamine Receptors

  2003cited by this paper
• The Physiological Role of 5-HT2A Receptors in Working Memory

  2002cited by this paper
• Dopamine/Serotonin Receptor Ligands. Part IV [1]: Synthesis and Pharmacology of Novel 3‐Benzazecines and 3‐Benzazonines as Potential 5‐HT2A and Dopamine Receptor Ligands

  2002cited by this paper
• Pharmacological characterization of the benz[d]indolo[2,3-g]azecine LE300, a novel type of a nanomolar dopamine receptor antagonist

  2002cited by this paper
• Synthesis and 5‐HT2A Antagonist Activity of Derivatives of the Novel Heterocycles Indolo[3,2‐d]pyrrolo[3,2‐g]azecine and Benzo[d]pyrrolo[3,2‐g]azecine compared to the Benz[d]indolo[2,3‐g]azecine Derivative LE 300

  2001cited by this paper
• 7-Methyl-6,7,8,9,14,15-hexahydro-5H-benz[d]indolo[2,3-g]azecine: a new heterocyclic system and a new lead compound for dopamine receptor antagonists.

  2000cited by this paper
• Coupling of dopamine receptor subtypes to multiple and diverse G proteins

  2000cited by this paper
• Direct protein–protein coupling enables cross-talk between dopamine D5 and γ-aminobutyric acid A receptors

  2000cited by this paper
• 5-HT receptor classification and nomenclature: towards a harmonization with the human genome.

  1997cited by this paper
• Compounds selective for dopamine receptor subtypes

  1997cited by this paper
• SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

  1997cited by this paper
• Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors.

  1995cited by this paper
• In‐vitro Pharmacology of Sarpogrelate and the Enantiomers of its Major Metabolite: 5‐HT2A Receptor Specificity, Stereoselectivity and Modulation of Ritanserin‐induced Depression of 5‐HT Contractions in Rat Tail Artery

  1995cited by this paper
• Dopamine receptor pharmacology.

  1994cited by this paper
• Indoles. XI: Synthesis and stereochemistry of 5,6,7,8,13,16b-hexahydrobenz[a]indolo[2,3-h]quinolizines and of 5,6,7,8,13,13b-hexahydro-14H-bis-indolo[3,2-a][2,3-h]-quinolizine

  1994cited by this paper
• [Synthesis of the yohimbane skeleton from tryptamine and isochroman-3-ones (author's transl)].

  1977cited by this paper
• Zum Ablauf der Synthese von 1‐Methyl‐15,16,17,18,19,20‐hexadehydroyohimbanen aus 1‐Methyltryptamin und Isochroman‐3‐onen

  1977cited by this paper
• Aufbau des Yohimban‐Gerüstes aus Tryptamin und Isochroman‐3‐onen

  1977cited by this paper
• [The course of the synthesis of 1-methyl-15,16,17,18,19,20-hexadehydroyohimbanes from 1-methyltryptamine and isochroman-3-ones (author's transl)].

  1977cited by this paper
• The Classification of Adrenoceptors (Adrenergic Receptors). An Evaluation from the Standpoint of Receptor Theory

  1972cited by this paper
• Peripheral synthesis of medium-ring nitrogen heterocycles via .beta.-elimination reactions

  1972cited by this paper
• Neue Zweistufensynthese des Yohimban-Ringsystems

  1969cited by this paper

• Ring Expansion Reactions via C-N Bond Cleavage in the Synthesis of Medium-sized Cycles and Macrocycles

  2024cites this paper
• Advances in synthesis of novel annulated azecines and their unique pharmacological properties.

  2024cites this paper
• Research progress in biological activities of isochroman derivatives.

  2020cites this paper
• Design of new anti-Alzheimer drugs: ring-expansion synthesis and synchrotron X-ray diffraction study of dimethyl 4-ethyl-11-fluoro-1,4,5,6,7,8-hexahydroazonino[5,6-b]indole-2,3-dicarboxylate

  2018cites this paper
• Ring-expansion synthesis and crystal structure of dimethyl 4-ethyl-1,4,5,6,7,8-hexahydroazonino[5,6-b]indole-2,3-dicarboxylate

  2017cites this paper
• Breakthroughs in Indole and Indolizine Chemistry – New Synthetic Pathways, New Applications

  2016cites this paper
• Synthesis, characterization and biological evaluation of anti-cancer indolizine derivatives via inhibiting β-catenin activity and activating p53.

  2016cites this paper
• Robustness screen in enantioselective catalysis enabled generation of enantioenriched heterocyclic scaffolds in one pot.

  2015cites this paper
• Radiochemical synthesis and biological evaluation of 3-[4-(4-[18F]fluorobenzyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine as dopamine D4 receptor radioligand

  2014cites this paper
• Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders.

  2013cites this paper
• Highly β‐Regioselective Friedel–Crafts Aminoalkylation of Pyrroles with Cyclic Perfluoroalkylated Imines

  2013cites this paper
• Synthesis and biological evaluation of 1-(4-(4-(4-[18F]fluorobenzyl)-1-piperazinyl)butyl)indolin-2-one as dopamine D4 receptor ligand

  2012cites this paper
• Synthesis of benzopyrano[3,4-c]pyridin-5-ones as dopamine D4 receptor ligands.

  2010cites this paper